羞辱
发表于 2025-3-26 23:11:45
Molecular Profiling of Liquid Biopsies for Precision Oncology, the methods and challenges to identify and validate prognostic signals, such as tumor burden or stage from CTC, targeted and nontargeted mutations from ctDNA, or noncoding RNAs from EVs. Finally, we review the current landscape of novel biomarkers and ongoing clinical trials for liquid biopsies to
压碎
发表于 2025-3-27 04:29:58
http://reply.papertrans.cn/24/2328/232736/232736_32.png
Chauvinistic
发表于 2025-3-27 05:57:52
http://reply.papertrans.cn/24/2328/232736/232736_33.png
怒目而视
发表于 2025-3-27 09:25:58
https://doi.org/10.1007/978-3-030-91836-1precision oncology; cancer genome; tumor microenvironment; precision medicine; systems biology; bioinform
同步信息
发表于 2025-3-27 17:08:57
http://reply.papertrans.cn/24/2328/232736/232736_35.png
Morphine
发表于 2025-3-27 19:00:34
http://reply.papertrans.cn/24/2328/232736/232736_36.png
为宠爱
发表于 2025-3-28 01:26:41
http://reply.papertrans.cn/24/2328/232736/232736_37.png
四海为家的人
发表于 2025-3-28 02:40:08
Lecture Notes in Earth Sciences genes accounting for various types of diseases including cancers. The advances in NGS have allowed the sequencing of the entire genome of patients and identification of disease-associated variants in a reasonable timeframe and cost. The core of the variant identification relies on accurate variant
AMBI
发表于 2025-3-28 10:16:22
http://reply.papertrans.cn/24/2328/232736/232736_39.png
Fibrin
发表于 2025-3-28 14:19:09
http://reply.papertrans.cn/24/2328/232736/232736_40.png